Trials / Unknown
UnknownNCT05070234
Genetic Diagnosis and Human Growth Hormone Treatment in Small for Gestational Age Children With Short Stature
Genetic Diagnosis and the Response to Recombinant Human Growth Hormone Treatment in Small for Gestational Age Children With Short Stature
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Chunxiu Gong · Academic / Other
- Sex
- All
- Age
- 2 Years – 20 Years
- Healthy volunteers
- Not accepted
Summary
This study is a multi-center, retrospective and non-interventional research. In this study, a total of 150 short children who were small for gestational age and had been treated with recombinant human growth hormone (rhGH) are selected for genetic testing. The aims of this study are to analyze the genetic etiology of SGA children with short stature, and to compare the efficacy and safety of rhGH treatment in subjects with different etiologies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | Blood collection for genetic analysis | Genetic tests in this study are sequential testing, including MS-MLPA, whole exome sequencing, whole genome sequencing, as well as RNA-seq. |
Timeline
- Start date
- 2021-10-11
- Primary completion
- 2022-08-30
- Completion
- 2022-08-30
- First posted
- 2021-10-07
- Last updated
- 2021-10-07
Source: ClinicalTrials.gov record NCT05070234. Inclusion in this directory is not an endorsement.